氯代磷酸双(2,4-二氯苯基)酯_宁波菲克斯药业有限公司_ChemCD

宁波菲克斯药业有限公司

BusinessType: TradingCompany
CountryRegion: CN
user_Name:
Tel: 86 (0) 574 62378411
Fax: 86 (0) 574 62378411
Address: 24F1 Yuanjing Building, Beilun District,315800 Ningbo, Zhejiang,CHINA
Net:http://www.facus-pharma.com

氯代磷酸双(2,4-二氯苯基)酯

CAT #:F120128614

pro_cdbregno	CCD00152439
Product_Name	氯代磷酸双(2,4-二氯苯基)酯
Cas No.
pro_molWeight	406.415
pro_formula	C12 H6 Cl5 O3 P

PriceAndStock

Cat #	pro_quantity	price	enqiury
F120128614	2G	USD 550.00	enqiury
F120128614	1G	USD 320.00	enqiury
F120128614	5G	USD 790.00	enqiury

Contact

*Email

*Password

Remember_me | forget_pwd

*user_Name

user_Tel

*CountryRegion

TO：

宁波菲克斯药业有限公司

*pro_quantity

eg: 10 kg

Standard

eg: Purity:>98%

*Subject

Detailed

<p>Dear Sir/Madam,</p>
		Please arrange to send us your most competitive offer for the following compound.<br/>
		氯代磷酸双(2,4-二氯苯基)酯 <br/>
		<table width="90%" style="line-height:16px;">
              <tr style="background:#E7E6E6;">
                <td>pro_catalogNo</td>
                <td>pro_quantity</td>
                <td>pro_purity</td>
              </tr>
              <tr>
              
                
                <td><a href="http://www.chemcd.com/supplier/facus-pharma_product_2745860.html" target="_blank">F120128614</a></td>
                <td>2G</td>
                <td></td>
                
                  </tr><tr>
                <td><a href="http://www.chemcd.com/supplier/facus-pharma_product_2745860.html" target="_blank">F120128614</a></td>
                <td>1G</td>
                <td></td>
                
                  </tr><tr>
                <td><a href="http://www.chemcd.com/supplier/facus-pharma_product_2745860.html" target="_blank">F120128614</a></td>
                <td>5G</td>
                <td></td>
                
                
              </tr>
            </table>
	  <br/>
	  <p>Thanks</p>

*captcha:

change

宁波菲克斯药业有限公司

宁波菲克斯药业有限公司

氯代磷酸双(2,4-二氯苯基)酯

PriceAndStock

Contact

Contact Us

CHEMCD

Product

SiteMap

Help_Center

WeChat